Established in April 2008, Xiamen Biotime is a hi-tech enterprise that specialized in R&D, production, and sales of POCT in vitro diagnostic devices and reagents. Biotime has successfully established the mature medical marketing channels during the past years. With the leading technologies, Biotime aims to develop superior IVD products that provide better solutions for health care and benefit people all over the world. 

Why Biotime?

Other Platforms

Except for immunofluorescence, Biotime also developed other platforms, including Chemiluminescence, Electrochemistry, HPLC and colloidal gold, etc. after the outbreak of COVID-19, Biotime actively took actions to fight against the pandemic and successfully researched and developed COVID-19 related products, during the period, Biotime has obtained 20+ registration certificates including FDA EUA, CE, CIBG and etc. Besides, we conducted performance verification in foreign authoritative institutions and got brilliant evaluation results from Barts Health in the UK, Amiens University Medical Center in France, HUS LAB Diagnostic Center in Finland, etc

Full Range POCT Solution

After a long time of R&D work, Biotime has served many people with its all series qualified products, such as Cardiac/ Hormones/ Inflammation/ Tumor/ Thyroid/ Diabetes/ Renal Injury/ Infectious disease products etc. At the same time, our products have highly recognized and become more and more popular in the market. At present, we have successfully got 64+ NMPA and 35+ CE certificates for POCT kits and instruments.

Supplier Chain

Invest the NRE tooling cost in major plastic supplier Various supplier chain program in place to ensure the delivery and inventory control ✔ VMI Hub for supplier ✔ Min-max Kanban pull ✔ JIT program with package and card supplier ✔ Weekly MRP process Earlier supplier engagement to improve the DFM (Design For Manufacture)

We care...

Biotime is committed to understanding the needs of the medical system, social care, government, and all human. Our R&D team invents with science developing and market-driven to cover the six major areas in not only diagnosis and medical care but also the sense of life. The thoughts out of the boundary lead the innovative R&D to serve the life.